talquetamab
janssen
['multiple myeloma', 'talquetamab']
more than 70% of heavily pretreated patients taking talquetamab for multiple myeloma see responses that deepen over time #ash22 
SVP, Content @MJHLifeSciences. Focused on creating innovative, expert-driven content @OncLive @MedEconomics @AJMC_Journal @Pharmacy_Times @MDMagazine plus more